vs
Immunovant, Inc.（IMVT）与TECHPRECISION CORP（TPCS）财务数据对比。点击上方公司名可切换其他公司
Immunovant, Inc.的季度营收约是TECHPRECISION CORP的1.2倍（$8.4M vs $7.1M），TECHPRECISION CORP净利率更高（-20.8% vs -899.0%，领先878.2%），Immunovant, Inc.同比增速更快（140.7% vs -6.9%），TECHPRECISION CORP自由现金流更多（$-827.0K vs $-59.8M）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
TechPrecision Corp是一家专业生产定制高精度金属部件与集成系统的制造商，服务航空航天、国防、医疗科技、可再生能源等核心领域，为欧美客户提供符合严苛行业标准的关键任务零部件。
IMVT vs TPCS — 直观对比
营收规模更大
IMVT
是对方的1.2倍
$7.1M
营收增速更快
IMVT
高出147.7%
-6.9%
净利率更高
TPCS
高出878.2%
-899.0%
自由现金流更多
TPCS
多$59.0M
$-59.8M
损益表 — Q4 FY2024 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $7.1M |
| 净利润 | $-75.3M | $-1.5M |
| 毛利率 | — | 5.4% |
| 营业利润率 | -896.2% | -19.1% |
| 净利率 | -899.0% | -20.8% |
| 营收同比 | 140.7% | -6.9% |
| 净利润同比 | -26.7% | -84.4% |
| 每股收益（稀释后） | $-0.50 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTTPCS
| Q4 25 | — | $7.1M | ||
| Q3 25 | — | $9.1M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | — | $9.5M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $8.9M | ||
| Q2 24 | — | $8.0M | ||
| Q1 24 | $8.4M | $8.6M |
净利润IMVTTPCS
| Q4 25 | — | $-1.5M | ||
| Q3 25 | — | $825.0K | ||
| Q2 25 | — | $-597.0K | ||
| Q1 25 | — | $112.0K | ||
| Q4 24 | — | $-799.0K | ||
| Q3 24 | — | $-601.0K | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | $-75.3M | $-5.1M |
毛利率IMVTTPCS
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 14.0% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 14.3% |
营业利润率IMVTTPCS
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | -6.3% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -9.1% | ||
| Q3 24 | — | -5.5% | ||
| Q2 24 | — | -16.8% | ||
| Q1 24 | -896.2% | -28.6% |
净利率IMVTTPCS
| Q4 25 | — | -20.8% | ||
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | -8.1% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | -10.5% | ||
| Q3 24 | — | -6.7% | ||
| Q2 24 | — | -18.3% | ||
| Q1 24 | -899.0% | -59.5% |
每股收益（稀释后）IMVTTPCS
| Q4 25 | — | $-0.15 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $0.01 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | — | $-0.16 | ||
| Q1 24 | $-0.50 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $50.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $8.0M |
| 总资产 | $666.4M | $32.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMVTTPCS
| Q4 25 | — | $50.0K | ||
| Q3 25 | — | $220.0K | ||
| Q2 25 | — | $143.0K | ||
| Q1 25 | — | $195.0K | ||
| Q4 24 | — | $165.0K | ||
| Q3 24 | — | $132.0K | ||
| Q2 24 | — | $44.8K | ||
| Q1 24 | $635.4M | $138.0K |
总债务IMVTTPCS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IMVTTPCS
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $9.1M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | — | $8.7M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $8.9M | ||
| Q2 24 | — | $7.9M | ||
| Q1 24 | $617.8M | $7.8M |
总资产IMVTTPCS
| Q4 25 | — | $32.8M | ||
| Q3 25 | — | $33.8M | ||
| Q2 25 | — | $32.1M | ||
| Q1 25 | — | $33.5M | ||
| Q4 24 | — | $32.2M | ||
| Q3 24 | — | $35.0M | ||
| Q2 24 | — | $35.7M | ||
| Q1 24 | $666.4M | $34.7M |
负债/权益比IMVTTPCS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $183.0K |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $-827.0K |
| 自由现金流率自由现金流/营收 | -714.4% | -11.7% |
| 资本支出强度资本支出/营收 | 1.8% | 14.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-214.6M | $-4.4M |
8季度趋势，按日历期对齐
经营现金流IMVTTPCS
| Q4 25 | — | $183.0K | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | — | $646.0K | ||
| Q1 25 | — | $396.0K | ||
| Q4 24 | — | $-570.0K | ||
| Q3 24 | — | $-532.0K | ||
| Q2 24 | — | $107.0K | ||
| Q1 24 | $-59.7M | $-452.0K |
自由现金流IMVTTPCS
| Q4 25 | — | $-827.0K | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | $-604.0K | ||
| Q1 25 | — | $-930.0K | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | $-2.0M | ||
| Q2 24 | — | $-94.0K | ||
| Q1 24 | $-59.8M | $-900.0K |
自由现金流率IMVTTPCS
| Q4 25 | — | -11.7% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | -8.2% | ||
| Q1 25 | — | -9.8% | ||
| Q4 24 | — | -22.9% | ||
| Q3 24 | — | -21.8% | ||
| Q2 24 | — | -1.2% | ||
| Q1 24 | -714.4% | -10.5% |
资本支出强度IMVTTPCS
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | 15.4% | ||
| Q3 24 | — | 15.9% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | 1.8% | 5.2% |
现金转化率IMVTTPCS
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMVT
暂无分部数据
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
